Medicare Enrolled
Dr. Evan Restelli, D.O.
Pulmonary Disease · Pollocksville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Restelli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Restelli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Restelli
Dr. Evan Restelli is a pulmonary disease specialist in Pollocksville, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Restelli performed 41,592 Medicare services across 3,475 unique beneficiaries.
Between the years covered by Open Payments, Dr. Restelli received a total of $7,462 from 29 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Restelli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NC
$7,462 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,592
Medicare services
Top 1% in NC for pulmonary disease
3,475
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,189 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tezepelumab injection, 1 mg An injection of tezepelumab-ekko, a medication administered in 1 mg doses. |
20,580 | $14 | $35 |
| Injection, mepolizumab, 1 mg | 16,200 | $22 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
787 | $90 | $229 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
467 | $16 | $116 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
372 | $10 | $51 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
370 | $61 | $1,154 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
304 | $128 | $326 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
201 | $91 | $245 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
181 | $39 | $195 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
179 | $19 | $120 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
179 | $37 | $158 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
156 | $0 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
136 | $8 | $20 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
103 | $461 | $1,977 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
103 | $29 | $46 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
100 | $275 | $350 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
100 | $440 | $1,847 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
95 | $8 | $58 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
83 | $128 | $457 |
| Injection, methylprednisolone acetate, 40 mg | 80 | $5 | $8 |
| New patient office visit, complex (60-74 min) | 77 | $150 | $432 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
72 | $29 | $46 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
61 | $72 | $98 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $64 | $170 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
54 | $16 | $55 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
52 | $10 | $64 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $60 | $176 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
41 | $3 | $35 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
36 | $56 | $327 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
35 | $24 | $228 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
34 | $95 | $1,105 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
32 | $14 | $38 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
29 | $35 | $100 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
25 | $28 | $186 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
23 | $27 | $75 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
21 | $13 | $80 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
20 | $5 | $78 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
19 | $44 | $815 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
15 | $8 | $55 |
| Kidney function blood test panel | 15 | $9 | $68 |
| Bronchoscopy A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera. |
13 | $0 | $805 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
13 | $4 | $48 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
12 | $15 | $89 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
12 | $22 | $36 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
90.9% medium
9.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,462
Total received (2018-2024)
Avg $1,066/year across 7 years
Top 24% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,462 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,207
2023
$1,646
2022
$1,729
2021
$899
2020
$131
2019
$457
2018
$393
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$664
GlaxoSmithKline, LLC.
$315
Inspire Medical Systems, Inc.
$260
GENZYME CORPORATION
$259
Regeneron Healthcare Solutions, Inc.
$193
Amgen Inc.
$88
Insmed, Inc.
$86
Grifols USA, LLC
$74
United Therapeutics Corporation
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Edwards Lifesciences Corporation
$38
Baxter Healthcare
$33
Merck Sharp & Dohme LLC
$32
Electromed, Inc.
$26
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,058
GlaxoSmithKline, LLC.
$1,785
GENZYME CORPORATION
$442
Amgen Inc.
$423
Boehringer Ingelheim Pharmaceuticals, Inc.
$413
Grifols USA, LLC
$361
Regeneron Healthcare Solutions, Inc.
$271
Inspire Medical Systems, Inc.
$260
United Therapeutics Corporation
$234
Baxter Healthcare
$221
Insmed, Inc.
$217
Genentech USA, Inc.
$145
EMD Serono, Inc.
$98
Novartis Pharmaceuticals Corporation
$91
Paratek Pharmaceuticals, Inc.
$83
Merck Sharp & Dohme LLC
$56
Mallinckrodt Hospital Products Inc.
$53
Edwards Lifesciences Corporation
$38
Advanced Respiratory, Inc
$27
Electromed, Inc.
$26
PFIZER INC.
$24
Alexion Pharmaceuticals, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$20
Mylan Specialty L.P.
$19
Medtronic, Inc.
$18
Jazz Pharmaceuticals Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
Shire North American Group Inc
$14
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 57.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Arikayce · BREO · BREZTRI · CINQAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Esbriet · FARXIGA · FASENRA · GLASSIA · Gonal-f · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · INTELLIS ADAPTIVESTIM · KEYTRUDA · Life 2000 Ventilation System · NUCALA · NURTEC ODT · NUZYRA · OFEV · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · SAPIEN 3 Ultra RESILIA · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · ULTOMIRIS · XOLAIR · Xembify · Xolair · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
8
Per 100K population
86.5
County median income
$55,659
Nearest hospital
ONSLOW MEMORIAL HOSPITAL
15.2 mi
15.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Restelli is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Restelli experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Restelli performed 20,580 tezepelumab injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Restelli receive payments from pharmaceutical companies?
Yes. Dr. Restelli received a total of $7,462 from 29 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Restelli's costs compare to other pulmonary diseases in Pollocksville?
Dr. Restelli's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Restelli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Pollocksville
Browse pulmonary diseases in Pollocksville ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology